[1]
|
Moreau, P., Attal, M. and Facon, T. (2015) Frontline Therapy of Multiple Myeloma. Blood, 125, 3076-3084.
https://doi.org/10.1182/blood-2014-09-568915
|
[2]
|
Kyle, R.A., Gertz, M.A., Witzig, T.E., Lust, J.A., Lacy, M.Q., Dispenzieri, A., Fonseca, R., Rajkumar, S.V., Offord, J.R., Larson, D.R., et al. (2003) Review of 1027 Patients with Newly Diagnosed Multiple Myeloma. Mayo Clinic Proceedings, 78, 21-33. https://doi.org/10.4065/78.1.21
|
[3]
|
Herrera, G.A. and Sanders, P.W. (2007) Paraproteinemic Renal Diseases That Involve the Tubule-Interstitium. Contributions to Nephrology, 153, 105-115. https://doi.org/10.1159/000096763
|
[4]
|
王质刚. 血液净化学[M]. 北京: 北京科学技术出版社, 2010.
|
[5]
|
Decourt, A., Gondouin, B., Delaroziere, J.C., Brunet, P., Sallée, M., Burtey, S., et al. (2016) Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis. Clinical Journal of the American Society of Nephrology, 11, 431-441. https://doi.org/10.2215/CJN.06290615
|
[6]
|
Dimopoulos, M.A., Roussou, M., Gavriatopoulou, M., Psimenou, E., Eleutherakis-Papaiakovou, E., Migkou, M., et al. (2016) Bortezomib-Based Triplets Are Associated with a High Probability of Dialysis Independence and Rapid Renal Recovery in Newly Diagnosed Myeloma Patients with Severe Renal Failure or Those Requiring Dialysis. American Journal of Hematology, 91, 499-502. https://doi.org/10.1002/ajh.24335
|
[7]
|
Cohen, G., Rudnicki, M., Schmaldienst, S. and Hörl, W.H. (2002) Effect of Dialysis on Serum/Plasma Levels of Free Immunoglobulinlight Chains in End-Stage Renal Disease Patients. Nephrology Dialysis Transplantation, 17, 879-883.
https://doi.org/10.1093/ndt/17.5.879
|
[8]
|
Fabbrini, P., Sirtori, S., Casiraghi, E., Pieruzzi, F., Genovesi, S., Corti, D., et al. (2013) Polymethylmethacrylate Membrane and Serum Free Light Chain Removal: Enhancing Adsorption Properties. Blood Purification, 35, 52-58.
https://doi.org/10.1159/000350849
|
[9]
|
Schwab, P.J. and Fahey, J.L. (1960) Treatment of Waldenstrom’s Macroglobulinemia by Plasmapheresis. The New England Journal of Medicine, 263, 574-579. https://doi.org/10.1056/NEJM196009222631202
|
[10]
|
Takagi, K., Kin, K., Itoh, Y., Enomoto, H. and Kawai, T. (1980) Human Alpha1-Microglobulin Levels in Various Body Fluids. Journal of Clinical Pathology, 3, 786-791. http://dx.doi.org/10.1136/jcp.33.8.786
|
[11]
|
Zucchelli, P., Pasquali, S., Cagnoli, L. and Ferrari, G. (1988) Controlled Plasma Exchange Trial in Acute Renal Failure Due to Multiple Myeloma. Kidney International, 33, 1175-1180. https://doi.org/10.1038/ki.1988.127
|
[12]
|
Clark, W.F., Stewart, A.K., Rock, G.A., Sternbach, M., Sutton, D.M., Barrett, B.J., Heidenheim, A.P., Garg, A.X. and Churchill, D.N. (2005) Canadian Apheresis Group: Plasma Exchange When Myeloma Presents as Acute Renal Failure: A Randomized, Controlled Trial. Annals of Internal Medicine, 143, 777-784.
https://doi.org/10.7326/0003-4819-143-11-200512060-00005
|
[13]
|
Burnette, B.L., Leung, N. and Rajkumar, S.V. (2011) Renal Improvement in Myeloma with Bortezomib plus Plasma Exchange. The New England Journal of Medicine, 364, 2365-2366.
https://doi.org/10.1056/NEJMc1101834
|
[14]
|
Szczepiorkowski, Z.M., Bandarenko, N., Kim, H.C., Kim, H.C., Linenberger, M.L., Marques, M.B., et al. (2007) Guidelines on the Use of Therapeutic Apheresis in Clinical Practice: Evidence-Based Approach from the Apheresis Applications Committee of the American Society for Apheresis. Journal of Clinical Apheresis, 22, 106-175.
|
[15]
|
Dhakal, B., Miller, S., Rein, L., Pathak, L.K., Gloria, L., Szabo, A., et al. (2020) Trends in the Use of Therapeutic Plasma Exchange in Multiple Myeloma. Journal of Clinical Apheresis, 35, 307-315.
|
[16]
|
Ray, P.K., Besa, E., Idiculla, A., Rhoads, J.E., Bassett, J.G. and Cooper, D.R. (1980) Extracorporeal Immunoadsorption of Myeloma IgG and Autoimmune Antibodies: A Clinically Feasible Modality of Treatment. Clinical and Experimental Immunology, 42, 308-314.
|
[17]
|
罗乐宣, 于宗周. 免疫吸附治疗多发性骨髓瘤伴肾功能衰竭初探[J]. 中华肾脏病杂志, 1998(3): 181.
|
[18]
|
卢方平. 超高通量(中-高截)血液透析的研究进展[J]. 中国血液净化, 2017, 16(4): 270-272.
http://dx.chinadoi.cn/10.3969/j.issn.1671-4091.2017.04.014
|
[19]
|
Vallée Alexandre, G., Leila, C., Hélène, L.-M., Laure, P., Chantal, C., Guillaume, C., Jean-Paul, C. and Bernard, C. (2011) Online High-Efficiency Haemodiafiltration Achieves Higher Serum Free Light Chain Removal than High-Flux haemodialysis in Multiple Myeloma Patients: Preliminary Quantitative Study. Nephrology, Dialysis, Transplantation, 26, 3627-3633. https://doi.org/10.1093/ndt/gfr180
|
[20]
|
Lamy, T., Henri, P., Lobbedez, T., Comby, E., Ryckelynck, J.-P., Ficheux, M., et al. (2014) Comparison between on-Line High-Efficiency Hemodiafiltration and Conventional High-Flux Hemodialysis for Polyclonal Free Light Chain Removal. Blood Purification, 37, 93-98. https://doi.org/10.1159/000357968
|
[21]
|
Bourguignon, C., Chenine, L., Bargnoux, A.S., Leray-Moragues, H., Canaud, B., Cristol, J.P. and Morena, M. (2016) Hemodiafiltration Improves Free Light Chain Removal and Normalizes κ/λ Ratio in Hemodialysis Patients. Journal of Nephrolog, 29, 251-257. https://doi.org/10.1007/s40620-015-0207-z
|
[22]
|
Gerth, H.U., Pohlen, Mi., Görlich, D., Thölking, G., Kropff, M., Beel, W.E., Pavenstädt, H., Brand, M. and Kümpers, P. (2016) Impact of High-Cut-Off Dialysis on Renal Recovery in Dialysis-Dependent Multiple Myeloma Patients: Results from a Case-Control Study. PLoS One, 115, e0154993. https://doi.org/10.1371/journal.pone.0154993
|
[23]
|
Bridoux, F., Carron, P.L., Pegourie, B., Alamartine, E., Augeul-Meunier, K., Karras, A., Joly, B., Peraldi, M.N., Arnulf, B., Vigneau, C., Lamy, T., Wynckel, A., Kolb, B., Royer, B., Rabot, N., Benboubker, L., Combe, C., Jaccard, A., Moulin, B., Knebelmann, B., Chevret, S. and Fermand, J.P. (2017) Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence among Patients with Myeloma Cast Nephropathy: A Randomized Clinical Trial. JAMA, 318, 2099-2110. https://doi.org/10.1001/jama.2017.17924
|
[24]
|
Hutchison, C.A., Heyne, N., Airia, P., Schindler, R., Zickler, D., Cook, M., Cockwell, P. and Grima, D. (2012) Immunoglobulin Free Light Chain Levels and Recovery from Myeloma Kidney on Treatment with Chemotherapy and High Cut-Off Haemodialysis. Nephrology, Dialysis, Transplantation, 27, 3823-3828. https://doi.org/10.1093/ndt/gfr773
|
[25]
|
Adriano, C., Albin, S., Johannes, T., Yuki, T. and Ambühl, P.M. (2016) Therapeutic Efficacy and Cost Effectiveness of High Cut-Off Dialyzers Compared to Conventional Dialysis in Patients with Cast Nephropathy. PLoS ONE, 11, e0159942. https://doi.org/10.1371/journal.pone.0159942
|
[26]
|
Hutchison, C.A., Bradwell, A.R., Cook, M., Basnayake, K., Basu, S., Harding, S., et al. (2009) Treatment of Acute Renal Failure Secondary to Multiple Myeloma with Chemotherapy and Extended High Cut-Off Hemodialysis. Clinical Journal of the American Society of Nephrology, 4, 745-54. https://doi.org/10.2215/CJN.04590908
|
[27]
|
Hutchison, C.A., Cook, M., Heyne, N., Weisel, K., Billingham, L., Bradwell, A., et al. (2008) European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy (EuLITE): A Randomised Control Trial. Trials, 9, Article No. 55. https://doi.org/10.1186/1745-6215-9-55
|
[28]
|
Mehta, S., Shtaynberg, N., Goldman, M., et al. (2012) Use of Continuous Venovenous Hemofiltration for Acute Renal Failure Due to Multiple Myeloma Cast Nephropathy. Hematology, 17, 229-231.
https://doi.org/10.1179/1607845412Y.0000000003
|
[29]
|
咸伟, 申捷, 王素娟, 祁云香, 罗志尚. 多发性骨髓瘤肾病并发慢性肾功能衰竭行连续性血液滤过的治疗观察[J]. 中国医药科学, 2013, 3(17): 69-71.
|
[30]
|
Bosch, J.P., Geronemus, R., Glabman, S., Lysaght, M., Kahn, T. and von Albertini, B. (1978) High Flux Hemofiltration. Artificial organs, 2, 339-342. https://doi.org/10.1111/j.1525-1594.1978.tb01617.x
|
[31]
|
Hasegawa, M., Kondo, F., Yamamoto, K., Murakami, K., Tomita, M., Nabeshima, K., Nakai, S., Kato, M., Ohashi, A., Arai, J., Hiki, Y., Ishii, J., Emi, N., Sugiyama, S. and Yuzawa, Y. (2010) Evaluation of Blood Purification and Bortezomib Plus Dexamethasone Therapy for the Treatment of Acute Renal Failure Due to Myeloma Cast Nephropathy. Therapeutic Apheresis and Dialysis, 14, 451-456. https://doi.org/10.1111/j.1744-9987.2010.00863.x
|
[32]
|
Li Cavoli, G., Passanante, S., Schillaci, O., Servillo, F., Zagarrigo, C., Li Cavoli, T.V., et al. (2017) Haemodiafiltration with Ultrafiltrate Regeneration in the Removal of Free Light Chains in Multiple Myeloma and Acute Kidney Injury. Nefrologia, 38, 337-338. https://doi.org/10.1016/j.nefro.2017.06.007
|